Main menu
CNS Tumour Classification, Nordics & Baltics User Meeting
October 1 2025, 8:30 AM - 4:00 PM CEST
Oslo, Norway

CNS Tumour Classification, Nordics & Baltics User Meeting

Wednesday 1 October 2025, 08:30 - 16:00 GMT - Oslo, Norway (time subject to change)

We are pleased to invite you to a one-day event on 1st October in Oslo, Norway.

Join us for a focused gathering that brings together the CNS brain tumour community from across the Nordics and Baltics. This meeting is hosted by Oxford Nanopore Technologies in collaboration with Oslo University Hospital.

The event is designed to foster collaboration among clinicians, researchers, and core facility experts who are advancing CNS tumour classification using Oxford Nanopore Technologies’ end-to-end sequencing solutions.

Whether you're an experienced user or just beginning your journey with nanopore sequencing, this is a unique opportunity to exchange insights, build connections, and shape the future of CNS tumour research.

Please save the date — we look forward to seeing you in Oslo!

This event is invitation only, if you feel this event is of interest to you, please contact penelope.shah@nanoporetech.com. There is no delegate fee for this event, but registration is required.

Agenda

Oslo, Norway

09:00am –15:30 pm CET

Agenda (subject to change)

Speaker

09:00 am–10:00 am

Registration/Coffee​

10:00 am–10:30 am

Oxford Nanopore Opening Words

Angela Serrano da Silva, Diagnostic Testing Solutions Manager, Oxford Nanopore Technologies

10:30 am–11:00 am ​

From the surgeon’s perspective – the impact of rapid comprehensive molecular diagnostics of CNS tumors

Einar Osland Vik-Mo MD, PhD, Oslo University Hospital, Norway

11:00 am–11:30 am​

From genome to clinic: the potential of Oxford Nanopore long-read sequencing in precision medicine

Ole Halfdan Larsen Department of Molecular Medicine, Aarhus University Hospital, Denmark

11:30 am–13:00 pm ​

Networking Lunch

13:00 pm–13:30 pm ​

Examining the potential application of Oxford Nanopore sequencing in a diagnostic setting

Kelly Eggleton, Principal Clinical Scientist Department of Clinical Neuropathology, King’s College Hospital, UK

13:30 pm–14:00 pm

To follow

Hege Elisabeth Giercksky Russnes MD, PhD, Oslo University Hospital, Norway

14:00 pm–14:15 pm

Short Networking break

14:15 pm–15:15 pm

Workshop + Short Presentation

Focus Area Clinicians Focus Area Wet Lab Focus Area Data Analysis

15:15 pm–15:30 pm

Oxford Nanopore Concluding Remarks

Oxford Nanopore Technologies

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag